Skip to main content

Mannitol/sorbitol topical Disease Interactions

There are 7 disease interactions with mannitol / sorbitol topical.

Major

Laxatives (applies to mannitol/sorbitol topical) inflammatory bowel disease

Major Potential Hazard, Moderate plausibility.

The use of laxatives is contraindicated in patients with inflammatory bowel disease. Patients with inflammatory bowel disease may experience colonic perforation with use of stimulant laxatives.

References

  1. "Product Information. Dulcolax (bisacodyl)." Ciba Self-Medication Inc PROD (2001):
  2. "Product Information. Fleet Bisacodyl (bisacodyl)." Fleet PROD
  3. "Product Information. Kondremul Plain (mineral oil)." Bristol-Myers Squibb PROD
  4. "Product Information. Neoloid (castor oil)." Paddock Laboratories Inc PROD (2001):
  5. "Product Information. SenoSol-X (senna)." Apothecon Inc (2022):
  6. "Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates)." Braintree Laboratories (2010):
View all 6 references
Major

Laxatives (applies to mannitol/sorbitol topical) intestinal obstruction disorders

Major Potential Hazard, Moderate plausibility. Applicable conditions: Gastrointestinal Obstruction

The use of laxatives is contraindicated in patients with intestinal obstruction disorders. Patients with intestinal obstruction disorders may need their underlying condition treated to correct the constipation. Some laxatives require reduction in the colon to their active form to be effective which may be a problem in patients with intestinal obstruction.

References

  1. "Product Information. Dulcolax (bisacodyl)." Ciba Self-Medication Inc PROD (2001):
  2. "Product Information. Fleet Bisacodyl (bisacodyl)." Fleet PROD
  3. "Product Information. Kondremul Plain (mineral oil)." Bristol-Myers Squibb PROD
  4. "Product Information. Fleet Mineral Oil Enema (mineral oil)." Fleet PROD (2001):
  5. "Product Information. Citrucel (methylcellulose)." SmithKline Beecham PROD (2001):
  6. "Product Information. Fleet Babylax (glycerin)." Alcon Laboratories Inc PROD (2001):
  7. "Product Information. SenoSol-X (senna)." Apothecon Inc (2022):
  8. "Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates)." Braintree Laboratories (2010):
View all 8 references
Major

Osmotic diuretics (applies to mannitol/sorbitol topical) fluid overload

Major Potential Hazard, Moderate plausibility. Applicable conditions: Congestive Heart Failure, Pulmonary Edema, Anuria, Dehydration

The use of osmotic diuretics is contraindicated in patients with anuria, severe dehydration, pulmonary edema, or severe cardiac decompensation. An increase in the tonicity of the blood may occur in these patients that could exacerbate these conditions.

References

  1. "Product Information. Fleet Babylax (glycerin)." Alcon Laboratories Inc PROD (2001):
  2. "Product Information. Ismotic PB (isosorbide)." Alcon Laboratories Inc PROD (2001):
Major

Sorbitol irrigation (applies to mannitol/sorbitol topical) fluid expansion

Major Potential Hazard, High plausibility. Applicable conditions: Renal Dysfunction, Congestive Heart Failure

The use of sorbitol solution for urologic irrigation is contraindicated in patients with anuria. In addition, sorbitol irrigation should be administered cautiously in patients with cardiopulmonary or renal dysfunction. Irrigating fluids may enter the systemic circulation, and absorption of large quantities of fluids containing sorbitol may significantly alter cardiopulmonary and renal dynamics. Before and during the urologic procedure, cardiovascular and renal status should be monitored, particularly if the volume absorbed is expected to produce a substantial expansion of the intravascular fluid (e.g., via opened prostatic veins in transurethral prostatectomies).

References

  1. "Product Information. Sorbitol (sorbitol)." B. Braun/McGaw Inc PROD (2001):
Moderate

Osmotic diuretics (applies to mannitol/sorbitol topical) hyperosmolar effects

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease, Psychosis, Diabetes Mellitus, Renal Dysfunction

The use of osmotic diuretics is associated with an increase in blood tonicity. Osmotic diuretics should be administered cautiously in patients with confused mental states, diabetes, congestive heart failure, severe dehydration, and cardiac, renal, or hepatic disease.

References

  1. "Product Information. Fleet Babylax (glycerin)." Alcon Laboratories Inc PROD (2001):
  2. "Product Information. Ismotic PB (isosorbide)." Alcon Laboratories Inc PROD (2001):
Moderate

Sorbitol (applies to mannitol/sorbitol topical) diabetes

Moderate Potential Hazard, High plausibility. Applicable conditions: Diabetes Mellitus

Sorbitol is converted to glucose in the body. The use of sorbitol is not recommended as an alternative sweetener in patients with diabetes. Sorbitol is one of the end products of glucose metabolism that results in some of the late complications of diabetes.

References

  1. "Product Information. Sorbitol (sorbitol)." B. Braun/McGaw Inc PROD (2001):
Moderate

Sorbitol (applies to mannitol/sorbitol topical) sodium imbalances

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Hypernatremia, Hyponatremia, Dehydration

Shift of sodium-free intracellular fluid into the extracellular compartment following systemic absorption of sorbitol irrigation may lower serum sodium concentration and aggravate preexisting-existing hyponatremia. Excessive loss of water and electrolytes may may also cause hypernatremia. Sustained diuresis from transurethral irrigation with sorbitol irrigation may obscure and intensify inadequate hydration or hypovolemia. Patients with sodium imbalances or dehydration should be closely monitored.

References

  1. "Product Information. Sorbitol (sorbitol)." B. Braun/McGaw Inc PROD (2001):

Mannitol/sorbitol topical drug interactions

There are 134 drug interactions with mannitol / sorbitol topical.


Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.